医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
RARE · Ultragenyx Pharmaceutical Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Ultragenyx Pharmaceutical Inc.（RARE）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $448K；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-19。
买入 Bought—
卖出 Sold$448K
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-15 | Horn Howard Chief Financial Officer | 卖出 Sell | 7,066 | $15.27 | $108K | SEC |
| 2026-09-15 | Huizenga Theodore Alan SVP, Chief Accounting Officer | 卖出 Sell | 1,283 | $13.57 | $17K | SEC |
| 2026-09-03 | Huizenga Theodore Alan SVP, Chief Accounting Officer | 卖出 Sell | 161 | $13.99 | $2K | SEC |
| 2026-08-03 | Horn Howard Chief Financial Officer | 卖出 Sell | 4,696 | $24.92 | $117K | SEC |
| 2026-08-03 | Parschauer Karah Herdman EVP and Chief Legal Officer | 卖出 Sell | 1,900 | $24.92 | $47K | SEC |
| 2026-07-01 | Horn Howard Chief Financial Officer | 卖出 Sell | 4,698 | $33.13 | $156K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-15 | Huizenga Theodore Alan Officer | 1,283 | $17K | 10b5-1 |
| 2026-08-03 | Horn Howard Officer | 4,696 | $117K | 10b5-1 |
| 2026-07-01 | Horn Howard Officer | 4,698 | $156K | 10b5-1 |
内部人 Insiders
Horn Howard、Huizenga Theodore Alan、Parschauer Karah Herdman